Sun Pharma drops 7.5 per cent on Sebi report

​New Delhi: Shares of Sun Pharmaceutical Monday dived 7.5 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters.  The company's shares fell 7.52 per cent to end at Rs 455.30 apiece on the BSE.

During the day, the stock declined 10.22 per cent to Rs 441.95. On the NSE, the scrip of the company slumped by 7.53 per cent to close at Rs 455.50. In terms of volume, over 48 lakh shares were traded on the BSE, while over 6 crore units changed hands on the NSE.